Affordable Access

deepdyve-link
Publisher Website

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors
  • Sandercock, Peter
  • Wardlaw, Joanna M
  • Lindley, Richard I
  • Dennis, Martin
  • Cohen, Geoff
  • Murray, Gordon
  • Innes, Karen
  • Venables, Graham
  • Czlonkowska, Anna
  • Kobayashi, Adam
  • Ricci, Stefano
  • Murray, Veronica
  • Berge, Eivind
  • Slot, Karsten Bruins
  • Hankey, Graeme J
  • Correia, Manuel
  • Peeters, Andre
  • Matz, Karl
  • Lyrer, Phillippe
  • And 3 more
Type
Published Article
Journal
The Lancet
Publisher
Elsevier
Publication Date
Jun 23, 2012
Volume
379
Issue
9834
Pages
2352–2363
Identifiers
DOI: 10.1016/S0140-6736(12)60768-5
PMID: 22632908
Source
Medline
License
Unknown

Abstract

UK Medical Research Council, Health Foundation UK, Stroke Association UK, Research Council of Norway, Arbetsmarknadens Partners Forsakringsbolag (AFA) Insurances Sweden, Swedish Heart Lung Fund, The Foundation of Marianne and Marcus Wallenberg, Polish Ministry of Science and Education, the Australian Heart Foundation, Australian National Health and Medical Research Council (NHMRC), Swiss National Research Foundation, Swiss Heart Foundation, Assessorato alla Sanita, Regione dell'Umbria, Italy, and Danube University.

Report this publication

Statistics

Seen <100 times